TuHURA Biosciences Files Q1 2025 10-Q

Ticker: HURA · Form: 10-Q · Filed: May 15, 2025 · CIK: 1498382

Sentiment: neutral

Topics: 10-Q, financials, pharmaceuticals

TL;DR

TuHURA Biosciences (HURA) filed their Q1 2025 10-Q. Check financials.

AI Summary

TuHURA Biosciences, Inc. filed a 10-Q for the period ending March 31, 2025. The company, formerly known as Kintara Therapeutics, Inc., is incorporated in Nevada and operates in the Pharmaceutical Preparations sector. Their business address is in Tampa, Florida.

Why It Matters

This filing provides investors with an update on TuHURA Biosciences' financial performance and operational status for the first quarter of 2025.

Risk Assessment

Risk Level: medium — As a 10-Q filing, it contains detailed financial information and disclosures that could reveal significant risks or opportunities for the company.

Key Numbers

Key Players & Entities

FAQ

What was TuHURA Biosciences' former company name?

TuHURA Biosciences, Inc./NV was formerly known as Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., and Berry Only Inc.

What is the fiscal year end for TuHURA Biosciences?

The fiscal year end for TuHURA Biosciences is December 31.

In which state is TuHURA Biosciences incorporated?

TuHURA Biosciences is incorporated in Nevada (NV).

What is the SIC code for TuHURA Biosciences?

The Standard Industrial Classification (SIC) code for TuHURA Biosciences is 2834, which corresponds to Pharmaceutical Preparations.

What is the business address of TuHURA Biosciences?

The business address of TuHURA Biosciences is 10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL 33612.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding TuHURA Biosciences, Inc./NV (HURA).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing